Skip to main content
. Author manuscript; available in PMC: 2021 Sep 7.
Published in final edited form as: Menopause. 2012 Nov;19(11):1267–1276. doi: 10.1097/gme.0b013e318255657f

Table 5.

Trabecular bone mineral characteristics at the distal femoral metaphysis as measured by pQCT.

Group Trabecular BMC
(mg/mm)
Trabecular Bone Area
(mm2)
Trabecular BMD
(mg/cm3)
Intact Control (a) 3.2 ± 0.2b*,c*,d*,e,f*,h*,i* 6.2 ± 0.1c*,e,h 516 ± 22b*c*,d*,f*,h*,i*
OVX (b) 2.2 ± 0.1a*,d*,f*,h* 6.5 ± 0.3c 333 ± 15a*,d*,f*,h*
OVX+E2 (c) 1.9 ± 0.3a*,d*,h* 5.6 ± 0.2a*,b,d,g*,h* 333 ± 45a*,d*,f*,h*
OVX+HLU (d) 1.0 ± 0.1a*,b*,c*,e*,g*,h*,i 6.2 ± 0.1c,e 160 ± 9a*,b*,c*,e*,g*,h*
OVX+E2+HLU (e) 2.4 ± 0.3a,d*,f,h* 5.6 ± 0.2a,d,g,h* 428 ± 53b,d*,f,h*
OVX+HLU+REAMB (f) 1.2 ± 0.1a*,b*,e,g*,h* 6.2 ± 0.2h 185 ± 17a*,b*,c*,e,g*,h*
OVX+E2+HLU+REAMB (g) 2.7 ± 0.3d*,f*,h* 6.7 ± 0.3c*,e 407 ± 55d*,f*,h*
OVX+HLU+REAMB+EX (h) 0.3 ± 0.1a*,b*,c*,d*,e*,f*g*,i* 6.9 ± 0.2a,c*,e*,f 44 ± 10a*,b*,c*,d*,e*,f*,g*,i*
OVX+E2+HLU+REAMB+EX (i) 1.9 ± 0.3a*,d,h* 6.3 ± 0.3 313 ± 48a*,h*

Values are Means ± SEM of n = 6-12/group. Letters a-f indicate differences from respectively labeled groups at p ≤ 0.05 or *p ≤ 0.01 (a = vs. Intact controls, b = vs. OVX, c = vs.OVX+E2, d = vs. OVX+HLU, e = vs. OVX+E2+HLU, f = OVX+HLU+REAMB, g = OVX+E2+HLU+REAMB), h = vs. OVX+HLU+REAMB+EX, i = vs. OVX+E2+HLU+REAMB+EX. BMC = Bone mineral content, BMD = bone mineral density.